Article
Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy.
The Journal of infectious diseases - 1 Dec 2001
Lathey J L, Tierney C, Chang S Y, D'Aquila R T, Bettendorf D M, Alexander H C, Santini C D, Hughes A M, Barroga C F, Spector S A, Landes J E, Hammer S M, Katzenstein D A
Abstract excerpt
Genotype data for CCR5, CCR2, and stromal cell-derived factor 1 (SDF-1) were obtained from 354 human immunodeficiency virus type 1 (HIV-1)-positive subjects who were being treated with nucleosides. Associations with HIV-1 load, HIV syncytium-inducing (SI) phenotype, CD4 cell count, and disease progression were analyzed. No differences in HIV-1 load or CD4 cell count were observed between wild type (+) and variant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.